187 related articles for article (PubMed ID: 36056741)
1. Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
Midgette B; Strunk A; Akilov O; Alavi A; Ardon C; Bechara FG; Cohen AD; Cohen S; Daveluy S; Del Marmol V; Delage M; Esmann S; Fisher S; Giamarellos-Bourboulis EJ; Glowaczewska A; Goldfarb N; Brant EG; Grimstad Ø; Guilbault S; Hamzavi I; Hughes R; Ingram JR; Jemec GBE; Ju Q; Kappe N; Kirby B; Kirby JS; Lowes MA; Matusiak L; Micha S; Micheletti R; Miller AP; Moseng D; Naik H; Nassif A; Nikolakis G; Paek SY; Pascual JC; Prens E; Resnik B; Riad H; Sayed C; Smith SD; Soliman Y; Szepietowski JC; Tan J; Thorlacius L; Tzellos T; van der Zee HH; Villumsen B; Wang L; Zouboulis C; Garg A
Br J Dermatol; 2022 Dec; 187(6):927-935. PubMed ID: 36056741
[TBL] [Abstract][Full Text] [Related]
2. Biologic use in hidradenitis suppurativa: patient perspectives and barriers.
De DR; Shih T; Fixsen D; Brooks B; Hsiao JL; Shi VY
J Dermatolog Treat; 2022 Nov; 33(7):3060-3062. PubMed ID: 35737883
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
Peterson GC; Preston A; Frieder J; Wang X; Paek SY
Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for the management of comorbidity in hidradenitis suppurativa.
Dauden E; Lazaro P; Aguilar MD; Blasco AJ; Suarez C; Marin I; Queiro R; Bassas-Vila J; Martorell A; García-Campayo J
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):129-144. PubMed ID: 28796920
[TBL] [Abstract][Full Text] [Related]
5. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
6. Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project.
Garg A; Neuren E; Cha D; Kirby JS; Ingram JR; Jemec GBE; Esmann S; Thorlacius L; Villumsen B; Marmol VD; Nassif A; Delage M; Tzellos T; Moseng D; Grimstad Ø; Naik H; Micheletti R; Guilbault S; Miller AP; Hamzavi I; van der Zee H; Prens E; Kappe N; Ardon C; Kirby B; Hughes R; Zouboulis CC; Nikolakis G; Bechara FG; Matusiak L; Szepietowski J; Glowaczewska A; Smith SD; Goldfarb N; Daveluy S; Avgoustou C; Giamarellos-Bourboulis E; Cohen S; Soliman Y; Brant EG; Akilov O; Sayed C; Tan J; Alavi A; Lowes MA; Pascual JC; Riad H; Fisher S; Cohen A; Paek SY; Resnik B; Ju Q; Wang L; Strunk A
J Am Acad Dermatol; 2020 Feb; 82(2):366-376. PubMed ID: 31279015
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated With Point-of-Care Treatment Decisions for Hidradenitis Suppurativa.
Garg A; Besen J; Legler A; Lam CS
JAMA Dermatol; 2016 May; 152(5):553-7. PubMed ID: 26843464
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
[TBL] [Abstract][Full Text] [Related]
9. The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
Ring HC; Yao Y; Maul JT; Ingram JR; Frew JW; Thorsen J; Nielsen ML; Wu JJ; Thyssen JP; Thomsen SF; Egeberg A
Br J Dermatol; 2022 Oct; 187(4):523-530. PubMed ID: 35603888
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa.
Reddy S; Strunk A; Jemec GBE; Garg A
JAMA Dermatol; 2020 Jan; 156(1):65-71. PubMed ID: 31721983
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Durability of Intravenous Ertapenem Therapy for Recalcitrant Hidradenitis Suppurativa.
Nosrati A; Ch'en PY; Torpey ME; Shokrian N; Ball G; Benesh G; Andriano TM; Zhu TR; Heibel HD; Hosgood HD; Campton KL; Cohen SR
JAMA Dermatol; 2024 Mar; 160(3):312-318. PubMed ID: 38353987
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa.
Shavit E; Dreiher J; Freud T; Halevy S; Vinker S; Cohen AD
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):371-376. PubMed ID: 24909646
[TBL] [Abstract][Full Text] [Related]
13. Topical 15% Resorcinol Is Associated with High Treatment Satisfaction in Patients with Mild to Moderate Hidradenitis Suppurativa.
Docampo-Simón A; Beltrá-Picó I; Sánchez-Pujol MJ; Fuster-Ruiz-de-Apodaca R; Selva-Otaolaurruchi J; Betlloch I; Pascual JC
Dermatology; 2022; 238(1):82-85. PubMed ID: 33887735
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A; Malviya N; Strunk A; Wright S; Alavi A; Alhusayen R; Alikhan A; Daveluy SD; Delorme I; Goldfarb N; Gulliver W; Hamzavi I; Jaleel T; Kimball AB; Kirby JS; Kirchhof MG; Lester J; Lev-Tov H; Lowes MA; Micheletti R; Orenstein LA; Piguet V; Sayed C; Tan J; Naik HB
J Am Acad Dermatol; 2022 May; 86(5):1092-1101. PubMed ID: 33493574
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa.
Wright S; Strunk A; Garg A
J Am Acad Dermatol; 2022 Jan; 86(1):55-60. PubMed ID: 34144081
[TBL] [Abstract][Full Text] [Related]
16. Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study.
Garg A; Geissbühler Y; Houchen E; Choudhary N; Arora D; Vellanki V; Srivastava A; Priyanka ; Darcy J; Richardson C; Kimball AB
Am J Clin Dermatol; 2023 Nov; 24(6):977-990. PubMed ID: 37378875
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Patient Satisfaction Associated With Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa.
Benesh G; Andriano TM; Hosgood HD; Cohen SR
J Cutan Med Surg; 2023; 27(4):350-357. PubMed ID: 37461296
[TBL] [Abstract][Full Text] [Related]
18. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients.
Shalom G; Freud T; Harman-Boehm I; Polishchuk I; Cohen AD
Br J Dermatol; 2015 Aug; 173(2):464-70. PubMed ID: 25760289
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis and hidradenitis suppurativa: A large-scale population-based study.
Kridin K; Shani M; Schonmann Y; Fisher S; Shalom G; Comaneshter D; Batat E; Cohen AD
J Am Acad Dermatol; 2023 May; 88(5):e231-e236. PubMed ID: 30502412
[TBL] [Abstract][Full Text] [Related]
20. Drug Survival of Biologics in Patients With Hidradenitis Suppurativa.
Ring HC; Maul JT; Yao Y; Wu JJ; Thyssen JP; Thomsen SF; Egeberg A
JAMA Dermatol; 2022 Feb; 158(2):184-188. PubMed ID: 34851360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
